Immunology and Microbiology
Amino Terminal Sequence
12%
Antibody Response
12%
Antibody Titer
7%
Antiviral Activity
6%
Autoimmunity
6%
Cell Surface
11%
COVID-19
26%
DNA RNA Hybridization
5%
DNA Virus
5%
Ebola Virus
12%
Epitope
12%
Gene Expression
5%
Glycoprotein
25%
Human Immunodeficiency Virus 1
37%
Immune Escape
6%
Immunoglobulin A
5%
Immunoglobulin M
5%
Influenza
5%
Influenzavirus A
12%
Interferon Alfa
12%
Interferon Type I
53%
Leukocyte
6%
Macrophage
16%
Monoclonal Antibody
20%
Myeloid
11%
Neutralization
20%
Neutralizing Antibody
30%
Nucleoprotein
5%
Programmed Death-Ligand 1
12%
Protein Tertiary Structure
12%
Quantitative Reverse Transcription Polymerase Chain Reaction
10%
Real-Time Polymerase Chain Reaction
6%
Receptor Binding
25%
Revertant
6%
RNA Extraction
10%
RNA Virus
6%
SARS Coronavirus
26%
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Spike
75%
Sterile Alpha Motif
12%
Tetherin
28%
Viral Entry
5%
Viral Load
5%
Viral Replication
7%
Virion
12%
Virus
28%
Virus Genome
5%
Virus Infectivity
8%
Vpx
6%
Xenotropic MuLV Related Virus
12%
Medicine and Dentistry
Antiviral Protein
12%
COVID-19
49%
Dinucleotide
12%
Disease Prevalence
5%
Diseases
7%
DNA RNA Hybridization
5%
Emergency Department
12%
Enzyme Linked Immunosorbent Assay
8%
Human Immunodeficiency Virus
14%
Immunoassay
29%
Infection
33%
Infection Control
6%
Lateral Flow Assay
12%
Nasopharyngeal Swab
5%
Nucleic Acid Analysis
5%
Plaque Assay
5%
Post-COVID-19
12%
Public Health
7%
Quantitative Reverse Transcription Polymerase Chain Reaction
12%
Real-Time Polymerase Chain Reaction
5%
Reverse Transcription Polymerase Chain Reaction
8%
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Virus
8%
Virus DNA
5%
Virus Infectivity
5%
Virus Nucleocapsid
8%
Virus Replication
5%
Virus RNA
9%
X-Ray Fluorescence Spectroscopy
5%
Xenotropic MuLV Related Virus
12%
Zinc Finger Protein
12%
Biochemistry, Genetics and Molecular Biology
Antiviral Protein
15%
Human Immunodeficiency Virus 1
25%
Janus Kinase 1
12%
RNA
18%
SARS Coronavirus
12%
Tetherin
28%
Virion
10%
Virus Infectivity
5%
Virus Replication
5%
Xenotropic MuLV Related Virus
12%